The Manila Declaration on the Drug Problem in the Philippines
Overview
Public Health
Affiliations
When Philippine President Rodrigo R. Duterte assumed office in 2016, his government launched an unprecedented campaign against illegal drugs. The drug problem in the Philippines has primarily been viewed as an issue of law enforcement and criminality, and the government has focused on implementing a policy of criminalization and punishment. The escalation of human rights violations has caught the attention of groups in the Philippines as well as the international community. The Global Health Program of the Association of Pacific Rim Universities (APRU), a non-profit network of 50 universities in the Pacific Rim, held its 2017 annual conference in Manila. A special half-day workshop was held on illicit drug abuse in the Philippines which convened 167 participants from 10 economies and 21 disciplines. The goal of the workshop was to collaboratively develop a policy statement describing the best way to address the drug problem in the Philippines, taking into consideration a public health and human rights approach to the issue. The policy statement is presented here.
Addressing an opportune time to revise the Philippine Comprehensive Dangerous Drugs Act of 2002.
Alibudbud R Lancet Reg Health West Pac. 2023; 37:100857.
PMID: 37520161 PMC: 10382915. DOI: 10.1016/j.lanwpc.2023.100857.
Smith A, De Ungria M, Villanueva F, Bhugra D, Liebrenz M Lancet Reg Health West Pac. 2023; 36:100844.
PMID: 37456529 PMC: 10344644. DOI: 10.1016/j.lanwpc.2023.100844.
The Stigma of Substance Use and Addiction Among Filipino Immigrants and in the Philippines.
Alibudbud R Subst Abuse. 2023; 17:11782218231166805.
PMID: 37051013 PMC: 10084525. DOI: 10.1177/11782218231166805.
Restar A, Quilantang M, Surace A, Ogunbajo A, Chan R, Adia A AIDS Educ Prev. 2022; 34(2):116-130.
PMID: 35438540 PMC: 10442844. DOI: 10.1521/aeap.2022.34.2.116.
Death in the time of Covid-19: Efforts to restore the death penalty in the Philippines.
Jose J, De Ungria M Forensic Sci Int Mind Law. 2022; 2:100054.
PMID: 35308868 PMC: 8924917. DOI: 10.1016/j.fsiml.2021.100054.